Minna Kellomäki Selected Research

Osteomyelitis

4/2013	An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.
10/2012	Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minna Kellomäki Research Topics

Disease

4	Inflammation (Inflammations) 01/2015 - 12/2004
4	Hyperplasia 01/2015 - 06/2005
4	Foreign-Body Reaction 06/2008 - 10/2006
3	Fibrosis (Cirrhosis) 05/2013 - 08/2007
2	Pathologic Constriction (Stenosis) 07/2016 - 05/2012
2	Vascular System Injuries 01/2015 - 06/2005
2	Wounds and Injuries (Trauma) 01/2015 - 06/2005
2	Osteomyelitis 04/2013 - 10/2012
2	Urinary Retention 03/2009 - 05/2008
1	Retinal Diseases 01/2020
1	Spontaneous Remission 01/2016
1	Hypertrophy 01/2015
1	Bacterial Infections (Bacterial Infection) 10/2012
1	Infections 10/2012
1	Pancreatitis 05/2012
1	Thrombosis (Thrombus) 06/2010
1	Aneurysm (Aneurysms) 06/2010
1	Eosinophilia 04/2009
1	Osteolysis 06/2008
1	Foreign Bodies (Foreign Body) 06/2008
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2008
1	Urethral Diseases 08/2007
1	Persistent Infection 12/2005
1	Weight Loss (Weight Reduction) 06/2004

Drug/Important Bio-Agent (IBA)

4	poly(lactide) (polylactic acid)IBA 01/2015 - 12/2005
2	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2013 - 10/2012
2	Indomethacin (Indometacin)FDA LinkGeneric 04/2009 - 08/2007
2	dilactideIBA 03/2009 - 05/2008
2	Pharmaceutical PreparationsIBA 08/2007 - 06/2005
2	PolymersIBA 06/2005 - 06/2004
1	Blood Substitutes (Artificial Blood)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	MetalsIBA 07/2016
1	Proteins (Proteins, Gene)FDA Link 07/2016
1	CollagenIBA 01/2016
1	muraglitazarIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013
1	CytokinesIBA 05/2013
1	GlucocorticoidsIBA 05/2013
1	tricalcium phosphateIBA 04/2013
1	caprolactoneIBA 04/2013
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2012
1	TrypsinogenIBA 05/2012
1	Phenobarbital (Luminal)FDA Link 06/2010
1	Dutasteride (Avodart)FDA Link 03/2009
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2009
1	polyethylene oxide-polybutylene terephthalate copolymerIBA 06/2008
1	poly(DTE carbonate)IBA 01/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2007
1	poly(desaminotyrosyl-tyrosine-ethyl ester carbonate)IBA 10/2006

Therapy/Procedure

9	Stents 07/2016 - 12/2004
1	Tissue Transplantation 01/2020
1	Self Expandable Metallic Stents 07/2016
1	Operative Surgical Procedures 05/2012
1	Therapeutics 05/2008